CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Svenstrup Niels SVP, Chem. Mfg & Controls | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-03-01 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2023-03-01 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2023-02-08 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise | +644 | $10.88 | $7K | 644 |
| 2023-02-08 | Goyal Jaya EVP, Res. & Preclin. Dev. | Sale | −644 | $17.00 | $11K | 0 |
| 2023-02-08 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise · Stock Option (Right to Buy) | −644 | 144,196 | ||
| 2023-02-07 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise | +3,679 | $10.88 | $40K | 3,679 |
| 2023-02-07 | Goyal Jaya EVP, Res. & Preclin. Dev. | Sale | −3,679 | $17.18 | $63K | 0 |
| 2023-02-07 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise · Stock Option (Right to Buy) | −3,679 | 144,840 | ||
| 2023-02-06 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise | +1,677 | $10.88 | $18K | 1,677 |
| 2023-02-06 | Goyal Jaya EVP, Res. & Preclin. Dev. | Sale | −1,677 | $17.04 | $29K | 0 |
| 2023-02-06 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise · Stock Option (Right to Buy) | −1,677 | 148,519 | ||
| 2022-12-19 | Svenstrup Niels SVP, Chem. Mfg & Controls | Option exercise | +10,000 | $2.71 | $27K | 10,000 |
| 2022-12-19 | Svenstrup Niels SVP, Chem. Mfg & Controls | Option exercise · Stock Option (Right to Buy) | −10,000 | 25,629 | ||
| 2022-10-03 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +22,686 | 22,686 | ||
| 2022-07-01 | Mellion Michelle L See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Purchase | +879,970 | $12.00 | $10.6M | 4,755,388 |
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +3,642,229 | 3,642,229 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,979,451 | $12.00 | $35.8M | 6,621,680 |
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,052,851 | 1,052,851 |
Page 9 of 11 · 211 trades